Market revenue in 2023 | USD 64.2 million |
Market revenue in 2030 | USD 107.3 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Manufacturing, Contract Development |
Key market players worldwide | Eurofins Scientific SE, WuXi Biologics (Cayman) Inc, Catalent Inc, AGC Inc, Siegfried Holding AG, Boehringer Ingelheim, FUJIFILM Holdings Corp, Samsung BioLogics, Rentschler Biopharma SE, Recipharm |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule drug substance cdmo market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 66.98% in 2023. Horizon Databook has segmented the South Africa large molecule drug substance cdmo market based on contract manufacturing, contract development covering the revenue growth of each sub-segment from 2018 to 2030.
The South African market is expected to exhibit growth owing to well-established infrastructure, diverse patient population, skilled researchers, presence of separate drug regulatory agency, and easy patient recruitment.
In Africa, the South Africa is the most developed owing to its well-established healthcare industry and presence of key companies. Companies conduct trials for HIV and tuberculosis and hire staff locally.
According to Pharma Boardroom, diversity in patient pool and huge investments in the field of research are making South Africa a strategic hub for clinical trials, which is increasing presence of CROs in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa large molecule drug substance cdmo market , including forecasts for subscribers. This country databook contains high-level insights into South Africa large molecule drug substance cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account